全球整形外科軟組織修復市場：規模、佔有率、趨勢和成長分析報告（2026-2034）

預計整形外科軟組織修復市場將從 2025 年的 359.4 億美元成長到 2034 年的 800.1 億美元，2026 年至 2034 年的複合年成長率為 9.3%。

由於運動傷害、創傷和退化性疾病的發生率不斷上升，全球整形外科軟組織修復市場正經歷強勁成長。這些手術包括韌帶、肌腱和軟骨的修復，從而改善患者的活動能力和生活品質。微創手術技術的日益普及和整形外科醫療設備的進步是推動市場擴張的主要因素。此外，人口老化也促進了市場需求的成長。

關鍵成長要素包括外科器械和用於軟組織修復的生物材料的技術進步。參與體育運動和身體活動的增加也導致受傷率上升，從而推動了市場需求。此外，醫療基礎設施的擴建和先進治療方法的廣泛應用也促進了市場成長。人們對更快康復和改善患者預後的日益關注正在推動創新。

未來，隨著醫療技術的不斷進步，整形外科軟組織修復市場預計將顯著成長。生物工程組織和再生醫學的發展將進一步豐富治療選擇。在新興市場，醫療投資的增加預計將創造巨大的成長機會。此外，持續的研發投入也將持續推動市場擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球整形外科軟組織修復市場：依治療部位分類

• 市場分析、洞察與預測
• 膝蓋
• 肩膀
• 髖關節
• 其他

第5章：全球整形外科軟組織修復市場：依產品類型分類

• 市場分析、洞察與預測
• 固定裝置
• 組織補片
• 腹腔鏡器械

第6章：全球整形外科軟組織修復市場：依手術類型分類

• 市場分析、洞察與預測
• 前十字韌帶
• 肩旋板
• 陰道脫垂
• 肱骨外上髁炎
• 跟腱
• 臀部肌腱
• 肱二頭肌腱固定手術
• 髖關節鏡檢查
• 十字韌帶修復
• 骨盆器官脫垂

第7章 全球整形外科軟組織修復市場：依最終使用者分類

• 市場分析、洞察與預測
• 醫院
• 門診部
• 整形外科診所

第8章 全球整形外科軟組織修復市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • LifeCell
  • Johnson & Johnson Services Inc
  • Smith+Nephew
  • BD
  • Wright Medical Group NV
  • Medtronic
  • LifeNet Health
  • Boston Scientific Corporation
  • Arthrex Inc
  • Integra Lifesciences
  • Tissue Regenix
  • JRF Ortho
  • RTI Surgical
  • MTF Biologics
  • Conmed Corporation

The Orthopedic Soft Tissue Repair Market size is expected to reach USD 80.01 Billion in 2034 from USD 35.94 Billion (2025) growing at a CAGR of 9.3% during 2026-2034.

The global orthopedic soft tissue repair market is experiencing strong growth due to the increasing incidence of sports injuries, trauma, and degenerative conditions. These procedures involve the repair of ligaments, tendons, and cartilage, improving mobility and quality of life. The rising adoption of minimally invasive surgical techniques and advancements in orthopedic devices are key factors driving market expansion. Additionally, the growing aging population is contributing to increased demand.

Key growth drivers include technological advancements in surgical tools and biomaterials used in soft tissue repair. The increasing participation in sports and physical activities is also leading to higher injury rates, boosting demand. Furthermore, the expansion of healthcare infrastructure and the growing availability of advanced treatment options are supporting market growth. The rising focus on faster recovery and improved patient outcomes is encouraging innovation.

Looking ahead, the orthopedic soft tissue repair market is expected to grow significantly with continuous advancements in medical technology. The development of bioengineered tissues and regenerative therapies will further enhance treatment options. Emerging markets are likely to provide substantial growth opportunities due to increasing healthcare investments. Additionally, ongoing research and innovation will continue to drive market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapeutic Site

• Knee
• Shoulder
• Hip
• Others

By Product Type

• Fixation Devices
• Tissue Patch
• Laparoscopic Instruments

By Procedure

• Anterior Cruciate Ligament
• Rotator Cuff
• Vaginal Prolapse
• Lateral Epicondylitis
• Achilles
• Gluteal Tendon
• Biceps Tenodesis
• Hip Arthroscopy
• Cruciate Ligaments Repair
• Pelvic Organ Prolapse

By End User

• Hospitals
• Ambulatory Centers
• Orthopedic Clinics

COMPANIES PROFILED

• LifeCell, Johnson Johnson Services Inc, SmithNephew, BD, Wright Medical Group NV, Medtronic, LifeNet Health, Boston Scientific Corporation, Arthrex Inc, Integra Lifesciences, Tissue Regenix, JRF Ortho, RTI Surgical, MTF Biologics, Conmed Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET: BY THERAPEUTIC SITE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Therapeutic Site
• 4.2. Knee Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Shoulder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hip Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product Type
• 5.2. Fixation Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Tissue Patch Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Laparoscopic Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Procedure
• 6.2. Anterior Cruciate Ligament Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Rotator Cuff Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Vaginal Prolapse Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Lateral Epicondylitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Achilles Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Gluteal Tendon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Biceps Tenodesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Hip Arthroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.10. Cruciate Ligaments Repair Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.11. Pelvic Organ Prolapse Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Orthopedic Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Therapeutic Site
  • 8.2.2 By Product Type
  • 8.2.3 By Procedure
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Therapeutic Site
  • 8.3.2 By Product Type
  • 8.3.3 By Procedure
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Therapeutic Site
  • 8.4.2 By Product Type
  • 8.4.3 By Procedure
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Therapeutic Site
  • 8.5.2 By Product Type
  • 8.5.3 By Procedure
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Therapeutic Site
  • 8.6.2 By Product Type
  • 8.6.3 By Procedure
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 LifeCell
  • 10.2.2 Johnson & Johnson Services Inc
  • 10.2.3 Smith+Nephew
  • 10.2.4 BD
  • 10.2.5 Wright Medical Group N.V
  • 10.2.6 Medtronic
  • 10.2.7 LifeNet Health
  • 10.2.8 Boston Scientific Corporation
  • 10.2.9 Arthrex Inc
  • 10.2.10 Integra Lifesciences
  • 10.2.11 Tissue Regenix
  • 10.2.12 JRF Ortho
  • 10.2.13 RTI Surgical
  • 10.2.14 MTF Biologics
  • 10.2.15 Conmed Corporation